Admission Price: Free to attend, please register to book your place
School of Health Sciences welcomes Dr. Stephen Minger to City, University of London for a lecture on 'Stem Cells and the Future of Healthcare’. The talk will be followed by a reception.
There has been significant interest in the therapeutic and scientific potential of stem cells since reconstitution of the haematopoietic system was first realised by bone marrow transplantation in the 1960s. The isolation of tissue-specific, multipotent stem cells from adult organs and the derivation of pluripotent human embryonic stem cells offer the potential for regeneration of a number of different tissues and organs susceptible to age-related degenerative conditions and traumatic injury. In the not-too-distant future, it will be possible to repair heart tissue damaged by myocardial infarction, to replace neuronal cells lost in Parkinson’s and Alzheimer’s diseases, to transplant new insulin producing cells for diabetics and myelinating cells for individuals afflicted with multiple sclerosis, and to replace bone and cartilage lost through aging and inflammatory disease. In addition, the generation of specific populations of defined subtypes of human cells has tremendous potential to revolutionize the fields of drug discovery and investigation into the cellular bases of human disease. The newly emerging field of Regenerative Medicine will fundamentally alter clinical medicine and significantly influence our perceptions of aging, health and disease, with a myriad of consequences for society at large.
About the speaker
Dr. Stephen Minger received his PhD in Pathology (Neurosciences) in 1992 from the Albert Einstein College of Medicine in New York City. After post-doctoral work in central nervous system gene therapy, neural transplantation and neural stem cell biology at UCSD he moved to the UK in 1996 and was appointed a Lecturer in Biomolecular Sciences at King's College London in 1998. He was appointed a Senior Lecturer in Stem Cell Biology in 2005 and was the Director of the Stem Cell Biology Laboratory from 2002 until joining GE Healthcare in 2009 as the Global Director for Research and Development for Cell Technologies and then in 2013 became Chief Scientist for Cellular Sciences at GE Healthcare Life Sciences where he was responsible for long-term global research strategy for technology development in cell therapy, regenerative medicine, cellular technologies, in vivo diagnostic imaging and precision diagnostics.
Over the past 20+ years, Stephen’s research group has been at the forefront of human stem cell research. In 2002, his research team was awarded one of the first two licenses granted by the UK Human Fertilisation and Embryology Authority for the derivation of human embryonic stem (hES) cells. The group was one of the first in the UK to be granted a research license by the HFEA to pursue Somatic Cell Nuclear Transfer (SCNT) to generate “hybrid human embryos” for fundamental research into genetic forms of neurodegenerative conditions. He was actively involved with the UK Department of Health and with the Minister for Public Health in the consultation with both Houses of Parliament that led to the passage of the Human Embryo Bill of 2009 and the inclusion of new forms of animal-human embryos within primary legislation.
Stephen was the Stem Cell Expert and a Member of the UK Gene Therapy Advisory Committee (GTAC) at the Department of Health, the Focal Point for Regenerative Medicine, Drug Discovery and Modernisation of Traditional Chinese Medicine in China for the UK Department of Business, Innovation and Skills from 2006-2009. He has numerous external consultancies including the European Commission Framework Programmes (FP6, FP7 and Horizon 2020) and is a member of the Board of Directors of the Canadian Centre for the Commercialisation of Regenerative Medicine (CCRM).
5:30pm - Registration
6:00pm - Lecture including the opportunity for Q&A
7:00pm - Reception with wine and nibbles
8:00pm - Close